Karolina Konstantynowicz‐Nowicka

The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders

A. Chabowski, Tomasz Charytoniuk, Hubert Żywno, 2022, International journal of molecular sciences.

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

A. Chabowski, Tomasz Charytoniuk, Hubert Żywno, 2021, Journal of clinical medicine.

Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life

A. Chabowski, K. Muszyńska-Rosłan, M. Krawczuk-Rybak, 2022, Cancers.

Myocardial Lipid Profiling During Time Course of High Fat Diet and its Relationship to the Expression of Fatty Acid Transporters

J. Górski, M. Baranowski, A. Chabowski, 2015, Cellular Physiology and Biochemistry.

Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway

E. Harasim-Symbor, A. Chabowski, Hubert Żywno, 2021, Molecules.

Additive effects of dexamethasone and palmitate on hepatic lipid accumulation and secretion.

E. Harasim-Symbor, A. Chabowski, Karolina Konstantynowicz‐Nowicka, 2016, Journal of molecular endocrinology.

New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance

M. Baranowski, A. Chabowski, E. Harasim, 2015, PloS one.

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats

E. Harasim-Symbor, A. Chabowski, Tomasz Charytoniuk, 2022, International journal of molecular sciences.

The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes

E. Harasim-Symbor, A. Chabowski, Hubert Żywno, 2021, Biomolecules.

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD

E. Harasim-Symbor, A. Chabowski, Karolina Konstantynowicz‐Nowicka, 2021, International Journal of Molecular Sciences.